Managing patients with cancer and advanced liver disease

Palliative Medicine

Volumn 19, Issue 7, 2005, Pages 563-565

  Ford Dunn, Suzanne ^a  

^a St Barnabas Hospice   (United Kingdom)

Author keywords

Analgesia; Drug metabolism; Hepatic cirrhosis

Indexed keywords

ANALGESIC AGENT; DEXTROPROPOXYPHENE PLUS PARACETAMOL; HALOPERIDOL; LACTULOSE; MORPHINE; PARACETAMOL; PROPRANOLOL; SEDATIVE AGENT; SPIRONOLACTONE;

ABDOMINAL PAIN; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BONE METASTASIS; CANCER PATIENT; CASE REPORT; DRUG WITHDRAWAL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DISEASE; LIVER METASTASIS; MALE; PATIENT CARE; PORTAL HYPERTENSION; PROTEIN RESTRICTION; STOMACH CARCINOMA;

ACETAMINOPHEN; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA; HUMANS; LIVER CIRRHOSIS; MALE; MORPHINE DERIVATIVES; PAIN; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 27844506032     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216305pm1047cr     Document Type: Article

References (15)

1. Donaldson L. Chief medical officer annual report on the state of the public health. London: Department of Health, 2001.
2. Jones EA. Hepatocellular failure. In Weatherall DJ, Ledingham JGG, Worrell DA eds. Oxford textbook medicine, third edition. New York: Oxford University Press, 1996.
3. McIntyre N, Burroughs AK. Cirrhosis, portal hypertension and ascites. In Weatherall DJ, Ledingham JGG, Worrell DA eds. Oxford textbook medicine, third edition. New York: Oxford University Press, 1996.
4. Riordan S, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-79.
5. Benson DG. Acetaminophen in chronic liver disease. Clin Pharmacol Ther 1983; 3: 95-101.
6. Remington H, Swallow R, Daly MJ, Bramley P. Drug choice in patients with liver disease. Pharm J 1992; 248: 845-48.
7. Seeff LB. Acetaminophen hepatotoxicity in alcoholics. Ann Int Med 1986; 104: 399-404.
8. Kotb HI, El-Kabsh Y, Emara S, Fouad E. Pharmacokinetics of controlled release morphine (MST) in patients with liver cirrhosis. Br J Anaesth 1997; 79: 804-806.
9. Tegeder I, Lotsche J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999; 37: 17-40.
10. Hasselstrom J, Eriksson S, Persson A, Rane A, Svensson JO, Sawe J. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol 1990; 29: 289-97.
11. Tallgren M, Olkkola K, Seppala T, Hockerstedt K, Lindgren L. Pharmacokinetics and ventilatory effects of oxycodone before and after transplantation. Clin Pharmacol Ther 1997; 61: 655-61.
12. Westphal JF, Brogard JM. Drug administration in chronic liver disease. Drug Saf 1997; 17: 47-73.
13. Danzinger LH, Martin SJ, Blum RA. Central nervous system toxicity associated with meperidine use in hepatic disease. Pharmacotherapy 1994; 14: 235-8.
14. Liver disease and drug disposition. Br J Anaesthesia. 1992; 68: 459-61.
15. Prabhaker S, Bhatia R. Management of agitation and convulsions in hepatic encephalopathy, Indian J Gastroenterol 2003; 22: S54-8.